Natalie Galanina,

Chicago Medical School, Chicago, IL

Internal Medicine – Yale University, New Haven, CT

Hematology and Oncology – University of Chicago, Chicago, IL

Hematology and Medical Oncology – American Board of Internal Medicine

Natalie Galanina, MD, a Hematologist-Oncologist, is an Associate Professor of Medicine and the Medical Director of Allogeneic Transplant at City of Hope^® Cancer Center Atlanta, where she focuses on diagnosing and treating hematologic malignancies across all stages, including both myeloid and lymphoid diseases. She has a particular interest in working with those diagnosed with acute myeloid leukemia and aggressive lymphomas.

Dr. Galanina’s path to medicine was distinctly personal. As a child, her grandfather passed away from advanced-stage colon cancer. Later in life, a close friend was diagnosed with breast cancer but received care that prioritized screening, innovative care and patient involvement in treatment choices, resulting in a positive outcome.

“These experiences collectively drew me toward oncology, a field that uniquely combines complex medical decision-making with the privilege of forming meaningful, long-term relationships with patients and families,” Dr. Galanina says. “I value the opportunity to guide patients through some of the most challenging moments of their lives, helping them navigate uncertainty with clarity, compassion and evidence-based care.”

In her clinical work, Dr. Galanina focuses on the fields of cellular therapeutics, transplant medicine and immunotherapy. She is also a researcher and scholar who has worked to develop clinical trials in both immuno- and cellular therapies, stem cell transplantation and minimal residual disease monitoring. One of her long-term goals is to develop personalized, biologically informed approaches to treatment that are unique to each patient, with the hope that precision medicine approaches may improve clinical outcomes for relapsed or refractory diseases.

In her role as Medical Director of Allogeneic Transplant, Dr. Galanina will continue to expand access to innovative clinical trials, strengthen City of Hope’s cellular therapy programs in the Atlanta Southeast region and advance its stem cell transplantation capabilities.

“I am especially motivated by the opportunity to bring leading-edge therapies and clinical trials directly to patients, expanding access to treatments that can improve outcomes and, in many cases, offer hope where limited options previously existed,” she says.

After earning her medical degree at Chicago Medical School, Dr. Galanina completed an internship and residency at Yale University in New Haven, Connecticut, followed by a hematology and oncology fellowship at the University of Chicago. Prior to joining City of Hope, she held positions at the University of California San Diego and the University of Pittsburgh.

Dr. Galanina is an active member of several leading professional organizations, including the American Association for Cancer Research and the American Society of Hematology. She has participated in numerous grant-funded clinical trials, including studies conducted through the National Cancer Institute's Experimental Therapeutics Clinical Trials Network (ETCTN), and has assumed leadership roles in the development and conduct of investigator-initiated and early-phase studies. Her scholarly contributions include an extensive record of peer-reviewed publications and presentations at national scientific meetings.

In her free time, Dr. Galanina enjoys biking, kayaking, traveling and visiting the country’s national parks.